ATC Group: A04AA05 Palonosetron

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A04AA05 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Antiemetics and antinauseants
3
Antiemetics and antinauseants
4
Serotonin (5HT3) antagonists
5
A04AA05
Palonosetron

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.5 mg
PAREN - Parenteral
0.25 mg

Active ingredients in A04AA05

Active Ingredient
Description

Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor.

Medicines in this ATC group

Drug
Countries

Australia Austria Canada Cyprus Estonia ...

South Africa

Turkey

Turkey

Turkey

Cyprus Estonia Lithuania Romania Spain ...

Turkey

South Africa

Brazil Mexico New Zealand South Africa

South Africa

Turkey

South Africa

Turkey

Turkey

Turkey

Turkey

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
Summary of Product Characteristics (SPC)
Medication Package Insert (MPI)
ZA